Document Type : Case Report

Authors

1 Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Department of Radiotherapy, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

3 Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

4 Department of Obstetrics and Gynecology, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandarabbas, Iran

Abstract

Clear cell carcinoma is believed to be one of the rare neoplasms of cervix uteri and vagina. The etiology and pathogenesis of clear cell carcinoma of the cervix are unclear, with scarce information about the clinical behavior, optimal management, and prognosis of the tumor. The current treatment options are based on the experiences accumulated on Squamous cell carcinoma and other types of adenocarcinoma. Prior Intrauterine exposure to diethylstilbestrol (DES) is presumed to be a predisposing factor for clear cell adenocarcinoma in young patients. Metastasis is uncommon, but local recurrence may occur. The cure rate of this disease is 85-90% in early stages with a small volume of tumors.  In this study, we report a rare case of clear cell carcinoma of the cervix in a 21-year-old woman, who had no exposure to DES (in-utero) or synthetic non-steroidal estrogen; therefore, the present research supports the hypothesis that the risk factors, other than DES exposure, play an important role in carcinogenesis.

Keywords

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination, and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.30476/mejc.2022.89566.1536

  1. Stolnicu S, Hoang L, Soslow RA. Recent advances in invasive adenocarcinoma of the cervix. Virchows Arch. 2019;475(5):537-549. doi: 10.1007/s00428-019-02601-0.
  2. Wang D, Zhao C, Fu L, Liu Y, Zhang W, Xu T. Primary clear cell adenocarcinoma of the cervix: A clinical analysis of 18 cases without exposure to diethylstilbestrol. Obstet Gynecol Int. 2019;2019:9465375. doi: 10.1155/2019/9465375.
  3. Jiang X, Jin Y, Li Y, Huang HF, Wu M, Shen K, et al. Clear cell carcinoma of the uterine cervix: clinical characteristics and feasibility of fertility-preserving treatment. Onco Targets Ther. 2014;7:111-6. doi: 10.2147/OTT.S53204.
  4. Ramesh K, S A S, P S, Desai RM, K A. Clear cell carcinoma of cervix in a 60- year-old woman: A case report. J Clin Diagn Res. 2014;8(8):OD01-2. doi: 10.7860/JCDR/2014/8428.4654.
  5. Nikam DS, Katke RD. Clear cell carcinoma of the uterine cervix: A case series of five patients. J Case Rep. 2013;3:455-9.
  6. Singh P, Nicklin J, Hassall T. Neoadjuvant chemotherapy followed by radical vaginal trachelectomy and adjuvant chemotherapy for clear cell cancer of the cervix: a feasible approach and review. Int J Gynecol Cancer. 2011;21(1):137-40. doi: 10.1097/IGC.0b013e3182011236.
  7. Chaudhuri T, Sharma D. Primary clear cell adenocarcinoma of the uterine cervix in a young woman not associated with diethylstilbestrol: A case report and review of literature. Clin Cancer Investig J. 2012;1(4):239-41. doi: 10.4103/2278-0513.106278.
  8. Herbst AL: Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES). Gynecol Oncol. 2000, 76:147-156. doi: 10.1006/gyno.1999.5471.
  9. Waggoner SE, Anderson SM, Van Eyck S, Fuller J, Luce MC, Herbst AL. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix. Obstet Gynecol. 1994;84(3):404-8.
  10. Hashiguchi M, Kai K, Nishiyama S, Nakao Y, Yokoyama M, Aishima S. Clear cell carcinoma of the uterine cervix presented as a submucosal tumor arising in a background of cervical endometriosis. Int J Gynecol Pathol. 2018;37(1):88-92. doi: 10.1097/PGP.0000000000000386.